News | News By Subject | News by Disease News By Date | Search News

Get Our FREE
Industry eNewsletter


Biotechnology Headlines from PR Newswire

Forces of Change Reshaping Corporate Libraries & Information Services
Amgen Announces 2014 Third Quarter Dividend
Global Metabolomics Market 2014-2018: Key Vendors are Agilent, Bio-Rad, Bruker, Human Metabolome and Metabolon
Syneron Announces Investor Meeting Focused on UltraShape U.S. Launch Update on September 17, 2014
Xybion Announces It Will Host International User Conference in Philadelphia
Galmed Pharmaceuticals Reports First Half 2014 Financial Results
Novogen And CanTx Appoint Contract Manufacturers To Produce Clinical Batches Of Cantrixil™
Is Europe Putting Cancer Research at Risk?
Sinovac to Host Conference Call to Report Second Quarter 2014 Unaudited Financial Results
Malvern Instruments Completes Acquisition of MicroCal and Announces Purchase of Archimedes Product From Affinity Biosensors
UC San Diego Medical Center Cuts Average ER Wait Time by 92 Minutes using the Geneva Healthcare Suite
QIAGEN Adds Promising Genomic Biomarkers for Assessing Prognosis in Treatment of Blood Cancers to Personalized Healthcare Pipeline
Asterias Biotherapeutics Announces Live Investor Webcast
Stem Cells In Sports Injuries, Joints And Muscular Pain
ECC Signs a Contract for the Finance, Design, and Construction of a Premier Cancer Institute in Ibadan, Nigeria
Alimera Sciences To Release Second Quarter 2014 Results
LSI Medience Corporation and Kineticos Sign Agreement Related to the Presepsin Biomarker in Sepsis Management and Treatment
Global Cell Culture Market 2014-2018: Key Vendors are Becton, Dickinson and Co, EMD, GE Healthcare, Lonza Group, Sigma Aldrich and Thermo Fisher Scientific
Global Genomics and Proteomics Analytical Instruments Market 2014-2018: Key Vendors are Agilent, Bio-Rad , F. Hoffmann, La Roche, Illumina, PerkinElmer and Thermo Fisher Scientific
CorMedix, Inc. Granted Extension of NYSE-MKT Listing
Kinex Pharmaceuticals Announces Allowance of the Investigational New Drug (IND) application for KX2-391 Ointment by the United States Food and Drug Administration (FDA)
National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS
Advanced Biologics publishes additional OsteoAMP® abstracts in The Bone and Joint Journal
Neogen comments on SenesTech
WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division
Xencor to Host Second Quarter 2014 Financial Results Webcast and Conference Call
MDxI Launches Data Resource Setting New Standard for Defining and Targeting US Clinical Laboratory Universe
WHEATON® Highlights Products at AACC 2014 Offering Unique Solutions for the Clinical Market
OncoGenex to Report Financial Results for Second Quarter 2014 on August 7, 2014
EasyOne Pro from ndd Medical Technologies Chosen Again as the Exclusive PFT Testing Technology in Phase 2 of COPDGene Study
Cypher Genomics Announces the Appointment of Adam Simpson as President and COO to Advance Transformative Genome Interpretation Technology English
Spherix Schedules Shareholder Update Call
Innovative Collaboration To Increase Awareness Of Bullous Pemphigoid, A Rare Autoimmune Disease Of The Skin
The Medicines Patent Pool (MPP) Broadens Collaboration with Gilead Sciences: Signs Licence for Phase III Medicine Tenofovir Alafenamide (TAF)
Pfenex Inc. Announces Pricing Of Initial Public Offering
Sangamo BioSciences Reports Second Quarter 2014 Financial Results
AuraSense Therapeutics Appoints Biotechnology Veteran David S. Snyder as Chief Financial Officer
truBrain Neuroscientists To Launch More Effective, Healthier Alternative To Energy Drinks On Indiegogo
Benefits and Safety of Pradaxa® (dabigatran etexilate mesylate) Repeatedly Confirmed
SURPASS Launches New Company Logo and Corporate Website, Symbolizing Transformation of Company Culture to Meet the Changing Needs of Clients in the Life Science Community Today.
Zenith Epigenetics Appoints Julie Cherrington as President and CEO English Spanish
AbbVie to Host Second-Quarter Earnings Conference Call
MSC and Cape Regional Medical Center Partner to Improve Cost, Quality and Outcomes
MedNet Appoints Clareece West As Chief Operating Officer
SonoSim LiveScan™ injects stark realism into medical simulation
Dotmatics Announce Speaker Line-up for User Group Meeting 2014
RVX-208 Reduces Major Adverse Cardiovascular Events (MACE) Significantly in Patients with Diabetes Mellitus English
Mezzion Pharma Initiates Clinical Development Program To Evaluate Udenafil In Adolescents With Single Ventricle Heart Defects English
Valentis Nanotech Signs MOU to Integrate Technology in Thermoplastics Production
Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse

< Prev Next >
PR Newswire - United Business Media